Related Experiment Video
Updated: Apr 26, 2026

Near Infrared Photoimmunotherapy for Mouse Models of Pleural Dissemination
Published on: February 9, 2021
Epigenetic remodeling combined with photodynamic therapy elicits anticancer immune responses
Malgorzata Wachowska1, Magdalena Gabrysiak1, Jakub Golab2
1Department of Immunology; Center for Biostructure Research; Medical University of Warsaw; Warsaw, Poland.
Abstract:
Photodynamic therapy has been shown to induce strong immunity against tumor cells expressing exogenous tumor-associated antigens (TAAs), including P1A antigen. Cancer cells can evade the immune system by epigenetic silencing of TAAs, while DNA methyltransferase inhibitors, such as 5-aza-2'-deoxycytidine (5-aza-dC) can restore the expression of silenced or downregulated TAA. Thus, epigenetic remodeling with 5-aza-dC combined with PDT can elicit robust and durable antitumor immunity.
Insights
Photodynamic therapy combined with epigenetic remodeling can enhance anti-tumor immunity. This approach restores tumor-associated antigen expression, leading to a stronger and lasting immune response against cancer cells.
Area of Science:
- Immunology
- Oncology
- Epigenetics
Background:
- Photodynamic therapy (PDT) can induce immunity against tumor cells expressing tumor-associated antigens (TAAs).
- Cancer cells can evade immune detection by epigenetically silencing TAAs.
- DNA methyltransferase inhibitors can restore TAA expression.
Purpose of the Study:
- To investigate the combination of epigenetic remodeling with 5-aza-2'-deoxycytidine (5-aza-dC) and PDT.
- To determine if this combination can enhance antitumor immunity.
Main Methods:
- Utilized 5-aza-dC to demethylate and restore silenced TAA expression.
- Applied PDT to induce immune responses against TAA-expressing tumor cells.
Main Results:
- The combination therapy demonstrated the ability to restore TAA expression in cancer cells.
- Epigenetic remodeling followed by PDT resulted in robust and durable antitumor immunity.
Conclusions:
- Combining epigenetic remodeling with 5-aza-dC and PDT is a promising strategy.
- This approach can overcome TAA silencing and elicit potent, long-lasting anti-cancer immune responses.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

